Clinical trial
A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in…
NCT00474630 · Orexigen Therapeutics, Inc, Industry · Completed
Key facts
| NCT number | NCT00474630 |
|---|---|
| Title | A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes |
| Official title | A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Naltrexone 32 mg Sustained Release (SR)/Bupropion 360 mg Sustained Release (SR) and Placebo in Obese Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | Orexigen Therapeutics, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity, Overweight, Diabetes Mellitus, Type 2 |
| Intervention type | Behavioral, Drug |
| Interventions | Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary therapy |
| Enrollment | 505 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | May 17, 2007 |
| Last update posted | Nov 21, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: